Financials

News Ideas Discussions Technicals Seasonals

EXPRS2 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Expres2ion Biotech Holding AB engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer. Its products and services include custom made proteins and reagents; transfection reagent; process development; feasibility studies; and licensing. The company was founded by Charlotte Dyring, Wian de Jongh, and Martin Roland Jensen in 2010 and is headquartered in Hørsholm, Denmark.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

EXPRS2 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company